Keyphrases
Myeloma
100%
Bone Disease
100%
Genetic Polymorphism
100%
Glycogen Synthase Kinase 3 (GSK3)
100%
Myeloma Cells
100%
Dickkopf-1 (DKK1)
100%
EPHX1
100%
TNFSF8
100%
SNP
60%
Insulin-like Growth Factor 1 Receptor (IGF1R)
20%
Arkansas
20%
Genomic DNA (gDNA)
20%
Complex Interactions
20%
Expression Level
20%
Patient Survival
20%
Bone Marrow Microenvironment
20%
Interleukin-4 (IL-4)
20%
Single nucleotide Polymorphism
20%
Regression Analysis
20%
Cellular Expression
20%
Bone Lesions
20%
Biological Relevance
20%
Eastern Cooperative Oncology Group
20%
Total Therapy
20%
Prognostic Model
20%
Southwest Oncology Group
20%
Lactic Dehydrogenase
20%
Myeloma Bone Disease
20%
Single nucleotide Polymorphism chip
20%
Medicine and Dentistry
Myeloma
100%
Single Nucleotide Polymorphism
100%
Myeloma Cell
100%
Genetic Polymorphism
100%
Bone Disease
100%
Oncology
40%
Bone Marrow Microenvironment
20%
Genomic DNA
20%
Lactate Dehydrogenase
20%
Bone Lesion
20%
Myeloma Bone Disease
20%
Interleukin 4
20%
Prognostic Model
20%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Myeloma Cell
100%
Genetic Polymorphism
100%
Bone Marrow Microenvironment
20%
Lactate Dehydrogenase Blood Level
20%
Interleukin 4
20%
Agricultural and Biological Sciences
Genetic Polymorphism
100%
Single Nucleotide Polymorphism
100%
Bone Marrow
20%
Genomic DNA
20%
Lactate Dehydrogenase
20%
Interleukin 4
20%
Pharmacology, Toxicology and Pharmaceutical Science
Myeloma
100%
Bone Disease
100%
Interleukin 4
14%
Genomic DNA
14%
Bone Lesion
14%
Lactate Dehydrogenase
14%